Article Information
History
- February 24, 2021.
Article Versions
- You are currently viewing Version 1 of this article (February 24, 2021 - 01:03).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Joseph E. Ebinger, MD, MS1,
- Justyna Fert-Bober, Phd1,2,
- Ignat Printsev, PhD3,
- Min Wu, MPH1,
- Nancy Sun, MPS1,
- Jane C. Figueiredo, PhD4,
- Jennifer E. Van Eyk, PhD1,2,
- Jonathan G. Braun, MD, PhD3,5,*,†,
- Susan Cheng, MD, MPH1,*,† and
- Kimia Sobhani, PhD5,*,†
- 1Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
- 2Advanced Clinical Biosystems Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA
- 3F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
- 4Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA
- 5Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA
- ↵†Correspondence. Kimia Sobhani, PhD, Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, phone (310) 423-5405, email kimia.sobhani{at}cshs.org; Susan Cheng, MD, MPH, Department of Cardiology, Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA, phone (310) 423-2726, email susan.cheng{at}cshs.org; and, Jonathan G. Braun, MD, PhD, F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars Sinai Medical Center, Los Angeles, CA, phone (310) 423-8717, email jonathan.braun2{at}cshs.org.
↵* Equal contribution
Posted February 24, 2021.
Prior COVID-19 Infection and Antibody Response to Single Versus Double Dose mRNA SARS-CoV-2 Vaccination
